News Search & Analytics
US Edition
Minimum 3 characters required!!
Report Based On Past 7 Days Data
16
Total Articles
10
Total Publisher Covering articles
5
Highest On 2017-01-20
0
Articles Got Popular On Social Media
advanced cancer treatment found in Articles in last 7 Days

Top Articles

Jan 19 Bristol-Myers Squibb Co on Thursday said it has decided not to seek accelerated U.S. approval for its combination of two immunotherapy drugs as an initial treatment for lung...
Bristol-Myers Squibb Co on Thursday said it has decided not to seek accelerated U.S. approval for its combination of two immunotherapy drugs as an initial treatment for lung cancer...
Bristol-Myers Squibb Co on Thursday said it has decided not to seek accelerated U.S. approval for its combination of two immunotherapy drugs as an initial treatment for lung cancer...
Why Merck & Co., Inc. (MRK) Stock Is Higher Today
-InvestorPlace - Fri Jan 20 13:03:59 EST 2017
Merck & Co., Inc. (NYSE:) stock is surging Friday as a major competitor fell a step behind the pharmaceutical company. Bristol-Myers Squibb Co (NYSE:) said it would not se...
FRIDAY, Jan. 20, 2017 -- Many U.S. patients with late-stage lung cancer do not receive treatments that could prolong their lives, a new study finds. Researchers at the University o...
Bristol-Myers Squibb Co on Thursday said it has decided not to seek accelerated U.S. approval for a combination of its two immunotherapy drugs as an initial treatment for lung canc...
TUESDAY, Jan. 17, 2017 -- Just a half hour a day of moderate physical activity could be potent medicine for patients with advanced colon cancer, preliminary research suggests. Stud...
Even a Little Daily Activity May Boost Colon Cancer Survival: Study
-MedlinePlus - Wed Jan 18 04:12:12 EST 2017
TUESDAY, Jan. 17, 2017 (HealthDay News) -- Just a half hour a day of moderate physical activity could be potent medicine for patients with advanced colon cancer, preliminary resear...
'Huge leap' in prostate cancer testing
-BBC News - Thu Jan 19 16:12:07 EST 2017
The biggest leap in diagnosing prostate cancer "in decades" has been made using new scanning equipment, say doctors and campaigners. Using advanced MRI nearly doubles the number of...
New YORK Bristol-Myers Squibb Co (BMY.N) shares fell 11 percent on Friday following Thursday's announcement that it would not seek accelerated approval of its immunotherapy drug co...
3 Biotechs Likely to Be Acquired in 2017 | Fox Business
-Fox Business - Sun Jan 22 10:17:40 EST 2017
The year is still young, but we've already seen acquisitions of Ariad and CoLucid. Which biotechs could be scooped up next in 2017? Here's why Clovis Oncology (NASDAQ: CLVS), Inter...
Successful Immunotherapy Requires System-Wide Immune Response
-Health Canal - Sat Jan 21 13:13:03 EST 2017
New research led by researchers from UC San Francisco and Stanford University has found that successful cancer immunotherapy appears to depend on whether the treatment can trigger ...
The promise of gene therapy for Eli and Ella, but not Calliope Joy
-Philly.com - Tue Jan 17 01:12:03 EST 2017
By the time 2-year-old Calliope Joy Carr, of Bala Cynwyd, was diagnosed with an incurable degenerative brain disease, two children with the same deadly ailment, just 20 miles away,...
Stocks edge up, snapping the Dow's five-day losing streak
-Los Angeles Times - Fri Jan 20 13:11:28 EST 2017
Materials companies led U.S. stocks modestly higher Friday, recouping much of the market's Thursday loss and snapping a five-day losing streak for the Dow Jones industrial average....
AP News in Brief at 9:04 p.m. EST
-Miami Herald - Tue Jan 17 16:11:43 EST 2017
Obama shortens Manning's term, grants clemency to hundreds WASHINGTON (AP) — President Barack Obama granted clemency to Chelsea Manning on Tuesday, allowing the transgender Army in...
AP News in Brief at 12:04 a.m. EST
-Miami Herald - Tue Jan 17 19:11:21 EST 2017
Obama shortens Manning's term, grants clemency to hundreds WASHINGTON (AP) — President Barack Obama granted clemency to Chelsea Manning on Tuesday, allowing the transgender Army in...
Advertisement